Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).
Clinical trial NCT06264674 · COMPLETED
Trial details
- NCT number
- NCT06264674
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-02-18
- Enrollment
- 827
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.